Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.690
+0.010 (0.60%)
At close: Oct 15, 2025, 4:00 PM EDT
1.700
+0.010 (0.59%)
After-hours: Oct 15, 2025, 7:12 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $62.64 million as of October 15, 2025. Its market cap has increased by 49.21% in one year.
Market Cap
62.64M
Enterprise Value
61.33M
1-Year Change
49.21%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $62.64M, an increase of 3,423.90%. That is a compound annual growth rate of 228.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 62.64M | 44.28% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |